Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cécile van Els

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Vaccine|November 22, 2005
Heterologous prime-boost strategy to overcome weak immunogenicity of two serosubtypes in hexavalent Neisseria meningitidis outer membrane vesicle vaccineThomas Luijkx, Harry van Dijken, Cécile van Els, et al.
Expert Review of Vaccines|February 7, 2009
Quality-control issues and approaches in vaccine developmentBernard Metz, Germie van den Dobbelsteen, Cécile van Els, et al.
Human Vaccines & Immunotherapeutics|November 27, 2014
Fast vaccine design and development based on correlates of protection (COPs)Cécile van Els, Siri Mjaaland, Lisbeth Næss, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Vaccine|November 22, 2005
Heterologous prime-boost strategy to overcome weak immunogenicity of two serosubtypes in hexavalent Neisseria meningitidis outer membrane vesicle vaccineThomas Luijkx, Harry van Dijken, Cécile van Els, et al.
Expert Review of Vaccines|February 7, 2009
Quality-control issues and approaches in vaccine developmentBernard Metz, Germie van den Dobbelsteen, Cécile van Els, et al.
Human Vaccines & Immunotherapeutics|November 27, 2014
Fast vaccine design and development based on correlates of protection (COPs)Cécile van Els, Siri Mjaaland, Lisbeth Næss, et al.
Pageof 1